The strong results of the Global Fund demonstrate a sustainable and transformative impact, calling for increased European investment
A year before its replenishment, the Global Fund has released its annual results report, showcasing remarkable progress in the fight against HIV, tuberculosis, and malaria, while also highlighting ongoing challenges that demand continued attention and increased support.
Since 2002, thanks to the Global Fund partnership, 65 million lives have been saved, and mortality rates from these three diseases have been reduced by 61%. In many countries, the Global Fund’s partnership has not only improved the quality of life for those directly and indirectly affected by the three diseases but has also contributed to increased life expectancy and a reduction in socio-economic inequalities, as well as progress in addressing human rights and gender equality health barriers.
In 2023, health programs fully recovered from the disruptions caused by the COVID-19 pandemic, demonstrating the resilience and effectiveness of Global Fund investments.
The Global Fund has continued to challenge the cost and access to essential health treatments and tools, leading to a 25% reduction in the price of antiretroviral medicines, bringing the annual cost of treating one person to about US$45[1]. The price of GeneXpert cartridges used for molecular diagnostics for tuberculosis has significantly decreased, and the Global Fund is now distributing next-generation mosquito nets in endemic countries.
The Global Fund’s investments in health systems are vital. Efforts to combat HIV, TB, and malaria have freed up valuable resources in health infrastructures, allowing for better coverage of other medical needs. In 2023, the Global Fund invested US$1.8 billion in strengthening health and community systems and plans to invest US$6 billion during the 2024-2026 cycle. This strategy not only supports the goal of universal health coverage but also boosts preparedness for future pandemics.
In a world facing multiple humanitarian, political, climate, and health crises, the Global Fund has shown great adaptability and flexibility, continuing to deliver essential health services, as seen in Ukraine and Sudan, while strengthening its partnership with governments and civil society actors.
The Global Fund’s efficiency is also evident in its return on investment. Since its creation in 2002, Global Fund disbursements of US$63 billion are estimated to have generated health gains worth US$1.2 trillion and direct productivity gains of US$400 billion.
However, significant challenges remain. Drug-resistant tuberculosis and the heightened impact of malaria due to climate change and insecticide resistance demand a swift and coordinated response. Additionally, respect for human rights and gender equity in access to healthcare remain critical issues, with significant barriers to achieving universal and equitable access to health services and tools.
European countries, as global leaders in international cooperation and solidarity, have played a crucial role in this partnership. The report clearly shows that every euro invested in the Global Fund translates into substantial savings and tangible improvements in public health. It is essential that we continue to support and reinforce these commitments to sustain progress and effectively address emerging challenges.
Hélène Berger, Executive Director of Friends of the Global Fund Europe, said: “As we approach the next funding period, it is imperative that European governments reaffirm their support for the Global Fund. By doing so, we contribute to improving health systems and to achieving sustainable and transformative socio-economic conditions for people.”
“By reinforcing our commitment to the Global Fund, we choose to advance a fair, sustainable, and resilient global health system for all. Let us ensure that this vital partnership remains a cornerstone of European countries’ global health diplomacy.”
READ THE GLOBAL FUND RESULTS REPORT
[1] The annual cost to treat one person was about US$10,000 when the Global Fund was created